Telehealth software for peptide and GLP-1 clinics

LUKE is a telehealth platform, built HIPAA-first, for cash-pay clinics that run peptide and GLP-1 programs. Intake, treatment plans, prescription records and patient messaging share one platform with the lead pipeline. The rules these programs face are covered in our published guides.

What peptide and GLP-1 programs have to get right

Claims

FDA's March 3, 2026 letters to 30 telehealth companies targeted marketing that implied compounded GLP-1 products match approved drugs, and marketing compounded drugs under the telehealth company's own name without making clear who compounds them (FDA).

Research-use labels

FDA's March 31, 2026 letter to Gram Peptides rejected "Research Use Only" disclaimers because the company's marketing showed products meant for human use (FDA letter).

Supply

As of October 30, 2026, FDA has proposed leaving semaglutide, tirzepatide and liraglutide off the 503B bulks list, and no final determination has been published (91 FR 23431).

Ad platforms

Google, Meta and TikTok each set their own rules for these programs. Our platform rules guide was last verified October 4, 2026.

How LUKE fits a peptide or GLP-1 clinic

  • A lead pipeline. An eight-stage lead pipeline with notes and templates, and leads that convert to patients.
  • Advertising. Location-based ad campaigns are available through LUKE's agency partner, Ernesto Cullari Media LLC, under a separate agreement. See paid advertising.
  • Intake and onboarding. Patient onboarding and intake, with intake answers encrypted at the field level.
  • Treatment plans. A treatment plan for each patient, in the same platform as intake, appointments and messages.
  • Prescription records. Kept in the same platform as intake, appointments and messages. Prescription dosing is encrypted at the field level.
  • Provider-patient messaging. Messages between the clinic and the patient, encrypted at the field level.
  • Staff AI. A patient brief, an open file and a draft reply for staff, behind a per-clinic switch with a daily spend limit. AI use is recorded.
  • Security. Field-level AES-256-GCM encryption, clinic-scoped data, a hash-chained, tamper-evident audit trail, and staff multi-factor sign-in in production. See LUKE security.

LUKE is built for cash-pay practices. Plan prices and onboarding fees are on the pricing section of the homepage.

Rules we track for peptide and GLP-1 programs

These guides are operator education, not legal or medical advice. Confirm your own obligations with counsel.

Frequently asked questions

What is LUKE?

LUKE is software for clinics. It is not a pharmacy, and it does not supply medications.

Is LUKE built for cash-pay peptide and GLP-1 clinics?

Yes. LUKE is built for cash-pay practices, where the patient pays the clinic directly.

Where can I read the advertising rules for these programs?

Start with the peptide advertising compliance guide and the Policy Watch. Both link to primary sources, and neither is legal advice.

Does LUKE run my ads?

Location-based ad campaigns are available through LUKE's agency partner, Ernesto Cullari Media LLC, under a separate agreement. They are not part of the LUKE software.

How is patient information protected?

Sensitive fields such as intake answers, prescription dosing and messages are encrypted individually with AES-256-GCM. Each clinic's data is scoped to that clinic. A hash-chained, tamper-evident audit trail records clinical and administrative actions, and administrators can verify it on demand. Staff sign in with multi-factor authentication in production, and production runs on AWS under an active AWS Business Associate Addendum. See LUKE security.

What does LUKE cost?

Plans are billed monthly with a one-time onboarding fee, and annual billing is 15% less. Current prices are on the pricing section of the homepage.

Other clinic types: TRT and HRT clinics · Med spas · Fitness and wellness

See LUKE for your clinic.

Book a consultation →